FDA regulatory affairs / edited by David Mantus, Douglas J. Pisano. - Third edition. - xii, 387 pages ; 24 cm

Includes bibliographical references and index.

Overview of FDA and drug development / Josephine C. Babiarz and Douglas Pisano -- What is an IND? / Michael R. Hamrell -- The new drug application / Charles Monahan and Josephine C. Babiarz -- Meetings with the FDA / Alberto Grignolo and Sally Choe -- FDA medical device regulation / Barry Sall -- A primer of drug/device law : what is the law and how do I find it? / Josephine C. Babiarz -- The development of orphan drugs / Scott N. Freeman -- CMC sections of regulatory filings and CMC regulatory Compliance during investigational and postapproval stages / Prabu Nambiar, Steven R. Koepke, and Kevin Swiss -- Overview of the GxPs for the regulatory professional / Bob Buckley, Robert Blanks, Kimberly J. White, and Tonya White-Salters -- FDA regulation of the advertising and promotion of prescription drugs, biologics, and medical devices / Karen L. Drake, Esq. -- The practice of regulatory affairs / David S. Mantus -- FDA advisory Committees / Christina A. McCarthy and David S. Mantus -- Biologics / Florence Kaltovich -- Regulation of combination products in the United States / John Barlow Weiner, Esq.

9781841849195 (hardcover : acidfree paper)

2013047346


United States. Food and Drug Administration.


Drug Approval--United States.
United States Government Agencies--United States.
Biological Products--standards--United States.
Equipment and Supplies--standards--United States.
Government Regulation--United States.

RM301.25 / .F37 2014

615/.19

QV 771

Copyrights © Nirma University 2018. All Right Reserved